文献速递产科母胎医学

意外性胎盘植入谱系疾病中的孕产妇结局:多学科团队的单中心经验

Maternal outcomes in unexpected placenta accreta spectrum disorders: single-center experience with a multidisciplinary team.
PubMed 文献 · Am J Obstet Gynecol · 2019-06-04

该单中心回顾性队列研究比较了2011年1月1日至2018年6月30日间经组织学证实的胎盘植入谱系疾病分娩中,意外诊断组与产前诊断组的孕产妇结局。意外组54/243例(22.2%),其估计失血量(2.4 L vs 1.7 L,P=.04)和红细胞输注单位数(4 vs 2,P=.03)均高于产前诊断组,尽管产前诊断组侵入深度更严重。

要点

  • 意外性胎盘植入谱系疾病占全部病例的22.2%(54/243)。
  • 意外组估计失血量2.4 L高于产前诊断组1.7 L(P=.04)。
  • 意外组红细胞输注4单位高于产前诊断组2单位(P=.03)。

核心结论

  • 本研究数据与母胎医学单位网络研究结果相反,显示产前诊断组结局更好,尽管该组严重胎盘侵入比例更高。
  • 作者将此归因于多学科方法和持续流程改进,并认为经验丰富的团队比胎盘侵入深度更重要。

研究设计与样本

  • 单中心回顾性队列研究,纳入2011年1月1日至2018年6月30日间学术转诊中心所有组织学证实的胎盘植入谱系疾病分娩。
  • 分娩时诊断者为意外组(病例),产前诊断者为产前诊断组(对照),共243例。

主要发现

  • 意外组54/243例(22.2%)。
  • 产前诊断组既往剖宫产率170/189(89.9%)高于意外组35/54(64.8%)(P<.001)。
  • 产前诊断组前置胎盘率135/189(74.6%)高于意外组19/54(37.3%)(P<.001)。
  • 产前诊断组侵入性/穿透性胎盘比例125/189(66.1%)高于意外组9/54(16.7%)(P<.001)。
  • 意外组估计失血量2.4 L(四分位距1.4-3)高于产前诊断组1.7 L(1.2-3)(P=.04);意外组红细胞输注4单位(1-6)高于产前诊断组2单位(0-5)(P=.03)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: In a 2015 Maternal-Fetal Medicine Units Network study, only half of placenta accreta spectrum cases were suspected before delivery, and the outcomes in the anticipated cases were paradoxically poorer than in unanticipated placenta accreta spectrum cases. This was possibly because the antenatally suspected cases were of greater severity. We sought to compare the outcomes of expected vs unexpected placenta accreta spectrum in a single large US center with multidisciplinary management protocol. STUDY DESIGN: This was a retrospective cohort study carried out between Jan. 1, 2011, and June 30, 2018, of all histology-proven placenta accreta spectrum deliveries in an academic referral center. Patients diagnosed at the time of delivery were cases (unexpected placenta accreta spectrum), and those who were antentally diagnosed were controls (expected placenta accreta spectrume). The primary and secondary outcomes were the estimated blood loss and the number of red blood cell units transfused, respectively. Variables are reported as median and interquartile range or number (percentage). Analyses were made using appropriate parametric and nonparametric tests. RESULTS: Fifty-four of the 243 patients (22.2%) were in the unexpected placenta accreta spectrum group. Patients in the expected placenta accreta spectrum group had a higher rate of previous cesarean delivery (170 of 189 [89.9%] vs 35 of 54 [64.8%]; P < .001) and placenta previa (135 [74.6%] vs 19 [37.3%]; P < .001). There was a higher proportion of increta/percreta in expected placenta accreta spectrum vs unexpected placenta accreta spectrum (125 [66.1%] vs 9 [16.7%], P < .001). Both primary outcomes were higher in the unexpected placenta accreta spectrum group (estimated blood loss, 2.4 L [1.4-3] vs 1.7 L [1.2-3], P = .04; red blood cell units, 4 [1-6] vs 2 [0-5], P = .03). CONCLUSION: Our data contradict the Maternal-Fetal Medicine Units results and instead show better outcomes in the expected placenta accreta spectrum group, despite a high proportion of women with more severe placental invasion. We attribute this to our multidisciplinary approach and ongoing process improvement in the management of expected cases. The presence of an experienced team appears to be a more important determinant of maternal morbidity in placenta accreta spectrum than the depth of placental invasion.

来源:Am J Obstet Gynecol,查看原文。版权归原作者所有。

引用

  1. Erfani H, Fox KA, Clark SL, et al. Maternal outcomes in unexpected placenta accreta spectrum disorders: single-center experience with a multidisciplinary team. Am J Obstet Gynecol. 2019. PMID: 31173748. doi:10.1016/j.ajog.2019.05.035

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。